Nothing here is medical advice or an endorsement of human use
Morris, VK, Yothers, G, Kopetz, S , Puhalla, S, Lucas, PC, Iqbal, A, Boland, P, Deming, DA, Scott, AJ, Lim, HJ, Jacobs, S, Hong, TS, Wolmark, N, George, TJ
We used treeArches to create a manual tree with three layers of granularity in cell type in our data
Indeed, one study in patients with T2D receiving GLP-1 RA therapy reported that individuals with a higher abundance of Faecalibacterium prausnitzii in the gut microbiota exhibited better glycemic control and lower levels of systemic inflammation, supporting a link between GLP-1based treatment, beneficial microbial signatures, and metabolicinflammatory outcomes (106)
[16] [17] These studies, involving tens of thousands of patients, have found no significant association between GLP-1 receptor agonist use and increased cancer incidence overall, including breast cancer specifically
Berrington de Gonzalez, A